| | | 54277 | | 10.12.1997 | | Boehringer Ingelheim (Schweiz) GmbH | | 22.12.2006 | | | | | | | | | | | 01.08. | | | | 01.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Sifrol 0,125 mg | Tabletten | Tablets (Pramipexol Dihydrochloride Monohydrate 0.125 mg) | N04BC05 | CI | | 02 | Sifrol 0,25 mg | Tabletten | Tablets (Pramipexol Dihydrochloride Monohydrate 0.25 mg) | N04BC05 | CI | | 03 | Sifrol 1,0 mg | Tabletten | Tablets (Pramipexol Dihydrochloride Monohydrate 1 mg) | N04BC05 | CI | | 05 | Sifrol 1,5 mg | Tabletten | Tablets () | N04BC05 | CI | | 06 | Sifrol 0,5 mg | Tabletten | Tablets (Pramipexol Dihydrochloride Monohydrate 0.5 mg) | N04BC05 | CI |
|
|
